Arkolith/Insider Trading/CYTK/Form 4

Callos Andrew

EVP, Chief Commercial OfficerCYTOKINETICS INC (CYTK) · full profile →Form 4 · filed Apr 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$492K
Net Open-Market Flow
-$492K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 15, 2026Sell(S)7K$66.02$492K59K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001061983-26-000036) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML